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Dental implants have become a well-accepted treatment option for patients 
with partial or complete edentulism. The long-term success of the endosseous 
dental implant depends not only on osseointegration, but on the healthy soft tissue 
interface that surrounds the implant. Peri-implantitis is defined as an inflammatory 
process affecting the supporting hard and soft tissue around an implant in func-
tion, leading to loss of supporting bone. Peri-implant mucositis has been defined 
as a reversible inflammatory reaction in the peri-implant mucosa surrounding 
an osseointegrated dental implant. Peri-implant mucositis is assumed to precede 
peri-implantitis. Data indicate that patients diagnosed with peri-implant mucositis 
may develop peri-implantitis, especially in the absence of regular maintenance 
care. However, the features or conditions characterizing the progression from 
peri-implant mucositis to peri-implantitis in susceptible patients have not been 
identified. The most common etiological factors associated with the development 
of peri-implantitis are the presence of bacterial plaque and host response. The risk 
factors associated with peri-implant bone loss include smoking combined with 
IL-1 genotype polymorphism, a history of periodontitis, poor compliance with 
treatment and oral hygiene practices, the presence of systemic diseases affecting 
healing, cement left behind following cementation of the crowns, lack of keratin-
ized gingiva, and previous history of implant failure There is strong evidence that 
there is an increased risk of developing peri-implantitis in patients who have a 
history of severe periodontitis, poor plaque control, and no regular maintenance 
care after implant therapy. Management of peri-implantitis generally works on the 
assumption that there is a primary microbial etiology. Furthermore, it is assumed 
that micro-organisms and/or their by-products lead to infection of the surrounding 
tissues and subsequent destruction of the alveolar bone surrounding an implant. 
A combination of surgical, open debridement, and antimicrobial treatment has 
been advocated for the treatment of peri-implantitis. Surgical intervention is 
required once a patient has bleeding on probing, greater than 5 mm of probing 
depth, and severe bone loss beyond that expected with remodeling. Access flaps 
require full-thickness elevation of the mucoperiosteum, facilitating debridement 
and decontamination of the implant surface via hand instruments, ultrasonic tips, 
or lasers. When necessary, surgical procedures may be used in conjunction with 
detoxification of the implant surface by mechanical devices, such as high-pressure 
air powder abrasion or laser.
Keywords: dental implant, peri-implant disease, peri-implant mucositis,  
peri-implantitis, periodontitis, risk factors
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1. Introduction
Dental implants have become a well-accepted treatment option for patients 
with partial or complete edentulism. The long-term success of the endosseous 
dental implant depends not only on osseointegration, but on the healthy soft tissue 
interface that surrounds the implant [1]. Dental implants are susceptible to disease, 
and they might develop inflammatory reactions, which might lead to peri-implant 
mucositis and/or peri-implantitis.
Peri-implant disease progresses quietly without pain and often starts with 
marginal bone loss. The factors responsible can be broadly classified as biological 
factors and biomechanical factors. The biological factors include progressive bone 
loss, bacterial infections, and microbial plaque [2]. Biological complications are 
grouped as early biological failures and late implant failures. The early failures 
are applied to inappropriate aseptic measures of the surgical implant [3], and late 
complications are typically infections caused by peri-implantitis and bacterial 
plaque. Peri-implantitis due to biomechanical factors are either prosthesis-related 
factors such as occlusal overload, residual cement, inadequate prosthetic placement, 
or inappropriate abutment angle and bruxism [4].
2. Definitions
2.1 Peri-implant mucositis
Peri-implant mucositis is defined as inflammation of the peri-implant mucosa 
around an osseointegrated implant without loss of the supporting bone. Clinical 
signs of peri-implant inflammation are bleeding and/or suppuration on probing, 
with or without increased probing depths [5, 6].
2.2 Peri-implantitis
Peri-implantitis is defined as a pathological condition characterized by 
inflammation in the peri-implant mucosa/connective tissue and progressive  
loss of the supporting bone around a dental implant. Clinical signs of peri-
implantitis are bleeding and/or suppuration on probing, increasing probing 
depths, and/or recession of the mucosal margin, in addition to radiographic 
bone loss compared to previous examinations. When a previous radiograph is 
not available, the following is indicative for the diagnosis of peri-implantitis: 
bone loss >3 mm in combination with bleeding on probing and pocket 
depth > 6 mm [5].
3. Diagnosis of peri-implantitis
The advanced case of peri-implantitis can be identifiable with the evidence 
of radiographic bone loss, mobility, and clinical signs of infection. The challenge 
is to diagnose the early stage of peri-implantitis that will aid in the prevention of 
further bone resorption and subsequent loss of the implant. Diagnosing peri-
implant diseases using periodontal probing and radiographs may be inaccurate 





Some of the clinical parameters used for the diagnosis are as follows [7]:
• Vertical destruction of the crestal bone,
• Formation of a peri-implant pocket >4 mm,
• Bleeding or suppuration after gently probing,
• Tissue redness and swelling,
• Mobility.
Developing biomarker technologies may offer possibilities in the diagnostic 
application. Although more research is needed, the assessment of proinflam-
matory cytokines (IL-1β, TNFα, MMP-8) in the peri-implant crevicular fluid 
may be of value to diagnose peri-implantitis and peri-implant mucositis but 
are, at this time, inappropriate to predict peri-implantitis because of the lim-
ited evidence of controlled longitudinal clinical trials. MMP-8 is a promising 
biomarker as an early signal of peri-implant inflammation [8]. Commercially 
available chair-side diagnostic tests for MMP-8 to detect peri-implant diseases 
are promising. Elevated levels of MMP-8 in peri-implant crevicular fluid (PICF) 
are associated with peri-implant inflammation, while low MMP-8 levels (<20 ng/
mL) indicate healthy peri-implant tissues. Pathologically elevated levels of 
MMP-8 (>20 ng/mL) can be detected by a quantitative MMP-8 chair-side device, 
ImplantSafe® [9].
4. Classification peri-implantitis
Currently, there is no standard classification system to classify the parameters 
and the severity of the peri-implant disease. Froum and Rosen [10] proposed a clas-
sification for peri-implant disease based on the disease severity. This classification 
includes three clinical stages:
Early: Pocket depth (PD) ≥ 4 mm (bleeding and/or suppuration on probing) 
Bone loss <25% of the implant length.
Figure 1. 
The clinical and radiographic appearance of peri-implantitis.
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Moderate: PD ≥ 6 mm (bleeding and/or suppuration on probing) bone loss 
25–50% of the implant length.
Advanced: PD ≥ 8 mm (bleeding and/or suppuration on probing) bone loss 
>50% of the implant length.
Bleeding on probing should be noted on two or more aspects of the implant, and 
bone loss is measured on the radiographs from the time of prosthetic loading to the 
current time. If the radiograph at prosthetic loading is not available, the earliest 
available radiograph following loading should be used [11].
5. Pattern of bone loss in peri-implantitis
The pattern of bone loss in peri-implantitis is classified into vertical, horizontal, 
and combined bone loss. The most common pattern of bone loss is vertical (65%) 
and then horizontal (22%), and the least common pattern is combined (13%) [11].
6. Prevalence of peri-implantitis
The prevalence of peri-implant mucositis and peri-implantitis has ranged from 
19 to 65% and 1 to 47%, respectively [12, 13]. A systematic review revealed that 
the frequency of peri-implant mucositis was 63.4% on the patient level and 30.7% 
on the implant level. The peri-implantitis prevalence was 18.8 and 9.6%. In smok-
ers, the frequency of peri-implantitis increased to 36.3% [11]. The prevalence of 
peri-implant mucositis at the patient level varied between 1.1 and 80% [14–19]. 
The prevalence of peri-implantitis at the patient level ranged from 1.4 to 53.3% 
[14, 15, 17–26].
7. Etiology of peri-implantitis
Peri-implantitis is a result of biofilm-induced inflammation in the soft tissue 
that subsequently triggers a host response, with possible tissue degradation [27]. 
Peri-implantits inflammation is initiated by the accumulated bacterial biofilm. The 
development of disease was initially studied in an experimental gingivitis model in 
animals (dogs) and humans, and a cause-effect relationship between de novo plaque 
formation and peri-implant mucositis was observed [28, 29].
Histopathological, the early biofilm-induced inflammatory host response in 
mucositis is comparable to that in gingivitis, but the lesion of the inflammatory 
connective tissue (ICT) is larger and extends apically to the junctional epithelium. 
The established biofilm results in a more pronounced host response, and the exten-
sion of the ICT lesion is even larger in size than that in gingivitis, with the increased 
amounts of inflammatory cells in peri-implant mucositis [30]. The inflammation 
is reversible after biofilm removal, and no difference between implant systems has 
been observed [29, 31, 32]. Peri-implantitis lesions investigated in experimental 
ligature-induced peri-implantitis in a dog model presented more aggressive tissue 
degradation at the implant site than teeth with periodontitis. A larger inflammatory 
infiltrate extending close to the crestal bone and more bone-resorbing osteoclasts 
were observed at the implant site. Spontaneous progression after ligature removal 
varied with different implant surfaces [33, 34]. Peri-implant inflammation devel-
ops when microbes activate the host’s innate and adaptive immune responses. 
Several cell types, such as epithelial cells, fibroblasts, stromal cells, endothelial 




chemokines, to recruit leukocytes. Leukocytes are recruited from blood vessels and 
tissues. Human biopsies revealed that the proportion of vascular structures was 
smaller within the peri-implant ICT lesion and greater lateral to the peri-implant 
ICT than reported for periodontitis lesions. Neutrophil granulocytes (polymorpho-
nuclear neutrophils [PMNs]) and monocytes/macrophages are prevalent close to 
the sulcus epithelium in the peri-vascular area and the center of the ICT. Although 
the ICT lesion is dominated by T and B lymphocytes and plasma cells, the inflam-
matory lesion has a more acute character in peri-implantitis than in chronic peri-
odontitis, with a larger proportion of PMNs and macrophages [35–37].
8. Risk factors associated with peri-implantitis
8.1 Poor plaque control and lack of regular supportive therapy
Poor plaque control and a lack of regular supportive therapy constitute the 
risk factors for developing peri-implantitis. A 5-year follow-up revealed a lower 
incidence of peri-implantitis with regular supportive care [20]. A 10-year follow-up 
study also revealed that patients on a regular maintenance program had less chances 
of developing peri-implantitis [38].
8.2 History of periodontitis
Patients who have lost teeth from periodontitis are treated with implants, and 
these patients may be more at risk of peri-implantitis disease. There is strong evi-
dence from longitudinal and cross-sectional studies that a history of periodontitis 
constitutes a risk factor for peri-implantitis. Systematic reviews have indicated that 
subjects with a history of periodontitis are at greater risk of peri-implant disease. 
Long-term follow-up studies also revealed a correlation between peri-implantitis 
development with periodontitis [38–40].
8.3 Genetic traits
Genetic trait studies are scarce, and the overall evidence is limited and incon-
clusive. The most thoroughly investigated genetic factor is interleukin (IL)-1 
composite gene polymorphism [41]. The genetic traits can influence susceptibility 
to peri-implantitis development in periodontitis patients, even if the inflammatory 
condition is under control at the time of implant placement. IL-1RN gene polymor-
phism was proposed as a risk factor for peri-implantitis [42]. The IL-1 genotype in 
combination with smoking was observed to affect implant failure [43]. The vascular 
endothelial growth factor (VEGF) may play a protective role in marginal bone loss, 
that is, peri-implantitis [36].
8.4 Diabetes mellitus
Based on the available data, no association was found between diabetes and peri-
implantitis. Although the role of distinct physiological mediators in pathogenesis is 
not fully understood, evidence suggests that pro-inflammatory gene expression in 
peri-implantitis regions is affected by glycemic control [44]. Patients with diabetes 
mellitus are more prone to peri-implantitis than non-diabetic subjects, and the poor 
metabolic control has been shown to provide a more favorable environment for 
infection and loss of implants [45]. Controlling the blood sugar level is critical in 
increasing the implant success rate in diabetic patients [46].
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8.5 Smoking
Smoking has a detrimental effect on tissue healing. Nicotine can reduce the 
nutrition to the tissues as a result of its vasoconstrictive effect on the blood vessels 
during the early osseointegration phase. Based on the available studies, smoking can 
be considered as a greatest identifiable risk factor for peri-implantitis. The extent 
of osseointegration as well as the plaque accumulation around dental implants 
was compromised among csmokers. A 10-year cohort study reported that peri-
implantitis developed for 28% of all implants in smokers, while the corresponding 
incidence was 6% of all implants in non-smokers [39]. Several cross-sectional stud-
ies also showed a higher prevalence of peri-implantitis among smokers [15, 47, 48]. 
A systematic review of prospective and retrospective studies indicated an enhanced 
risk of biological complications among smokers; similarly, a meta-analysis indicated 
an enhanced risk of implant failure among smokers [49]. Studies indicate smoking 
as the greatest identifiable and most often cited risk.
8.6 Keratinized mucosa
Compared to sites with a keratinized mucosa of greater than 2 mm, sites with 
a keratinized mucosa of less than 2 mm are associated with plaque accumulation 
followed by peri-implant inflammation in the soft tissue and radiographic bone loss 
[50]. The evidence is limited and controversial that the absence of a keratinized 
mucosa is a risk factor for peri-implantitis, but this factor may negatively affect 
self-performed oral hygiene (Figure 2) [50].
8.7 Excess cement and over-contoured supra-structures
Potential risk indicators that are indirectly related to plaque accumulation 
have been proposed; for example, constructions with excess cement may result 
in a higher prevalence of peri-implantitis than screw-retained constructions [51]; 
similar results were reported for over contoured crowns and supra-structures 
[52]. A wide emergence profile in the restoration contour was reported to cause an 
unhealthy state (Figure 3) [53].
8.8 Implant-related factors
The titanium particles from the implant surface may be present in the tissues 
after implant placement and may enhance infection-induced inflammation and 
Figure 2. 




activate macrophages [54]. Implant surface characteristics vary in terms of topogra-
phy, surface roughness, and chemical composition. Currently, most implants have a 
moderately rough surface with improved bone responses during initial healing after 
implant placement [55]. Marginal bone loss was found to be greater when implants 
with rough surfaces were used, and turned surfaces generally demonstrated the 
smallest marginal bone loss [56, 57].
8.8.1 Implant platform switching
The platform switch concept might influence the marginal bone loss. The theory 
is that the micro-gap is displaced medially causing less bone loss (Figure 4) [58–60].
8.8.2 Implant installation
It is advisable to have a minimum thickness of 2-mm bone in the anterior 
region and at least 1 mm in the posterior region to reduce soft and hard tissue 
Figure 3. 
A case of peri-implantitis consequent to over-contoured restoration.
Figure 4. 
Platform switching to prevent marginal bone loss and peri-implantitis.
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loss. The quality of bone in the region of implant placement is an important fac-
tor for the success [61].
8.9 Overload
Clinical signs of occlusal overloads, such as abutment fracture, loss of reten-
tion and/or signs of abrasive forces on supra-structures, seem to be an indirect but 
potential risk. The factors related to occlusal overload are probably related to the 
location of the implant, the deviation of the axis of the implant, and the incompat-
ibility of the implant dimensions and the prosthesis. Occlusal overload can lead to 
bone loss around the osseointegrated implants [4]. However, the evidence is limited 
concerning overload and its influence on the onset or progression of peri-implanti-
tis [41, 62]. In a dog model, occlusal overload did not induce marginal bone loss in 
implants with a healthy mucosa [63].
8.10 Parafunctional habits-bruxism
Bruxism is a movement disorder of the masticatory system that is character-
ized among others by teeth grinding and clenching during sleep as well as during 
wakefulness. Since there is no periodontal ligament between the implant and sur-
rounding bone, the occlusal load is directly transmitted [64]. Even though bruxism 
is likely to be a risk factor for mechanical complications in the implant periphery, it 
is unlikely to be a potential risk factor for biological complications [65].
8.11 Alcohol consumption
Alcohol consumption was investigated in one prospective study, which showed 
that an intake of more than 10 g of alcohol per day was related to peri-implantitis 
bone loss, as well as tobacco use, plaque, and inflammation [66].
8.12 Iatrogenic factors
The proposed potential risk of iatrogenic factors for the initiation and  
progression of peri-implantitis caused by implant mal-positioning, surgical 
trauma, and inadequate restoration abutment seating has not yet been clearly 
investigated [67].
9. Treatment
9.1 Treatment of peri-implant mucositis
The main goal is to detoxify the contaminated implant surface. Peri-implant 
mucositis can be managed by non-surgical methods. Methods such as mechanical 
implant cleaning with titanium or plastic curettes, ultrasonics, or air polishing 
can be used. Photodynamic therapy as well as local antiseptic medication such as 
chlorhexidine gluconate, hydrogen peroxide, sodium percarbonate, and povidone-
iodine can be used [68–70].
9.2 Treatment of peri-implantitis
The management of peri-implantitis relies on strategies of disinfection such as 




associated or not with anti-infective solutions, such as used for chemical plaque 
control. The strategy is to disinfect and to reduce the inflammation as well as 
restoration of the peri-implant tissue lost due to the disease progression, usually 
with regenerative approaches using biologics and/or growth factors. The treat-
ment of peri-implant infections comprises conservative and surgical approaches. 
Depending on the severity of the peri-implant disease, either a nonsurgical 
therapy alone or a combined with the surgical method can be used to resolve the 
situation.
9.3 Non-surgical therapy
Manual treatment approaches using curettes, ultrasonic and air polishing sys-
tems, laser-supported, and photodynamic therapy are used along with medications.
9.4 Mechanical therapy
The bleeding from the site can be controlled either with piezoelectric scalers as 
well as with hand instruments [71]. The manual curetting of the area can be done 
using special curettes made of Teflon, carbon, plastic, and titanium curettes than 
the conventional curettes to protect the implant surfaces [72, 73]. The efficiency 
of the ultrasonic curettage can be supplemented with the air polishing systems 
[74–77]. Though the abrasive air polishing medium can modify the surface of 
implants, the cell response and healing were compromised probably due to the 
contamination of the implant surface [74, 76]. The extent of re-osseointegration 
of titanium implants after air polishing therapy has been reported between 39 and 
46% with increased clinical implant attachment and pocket depth reduction [75]. 
The air polishing systems such as hydroxylapatite/tricalcium phosphate, hydrox-
ylapatite, glycine, titanium dioxide, water and air, phosphoric acid can be used 
depending on the surface topography of implants [74, 77].
9.5 Decontamination of the surface of the implant
Decontamination of the root surface is done by various methods such as air 
powder flow, saline wash, citric acid, laser, and hydrogen peroxide [78]. The 
electrochemical decontamination of the surface of the implant is an innovative 
technique that is being tested in preclinical studies [79]. Rubber cups have been 
shown to smoothen the titanium surface and significantly decrease roughness by 
removing surface debris. Polishing the implant surfaces with pumice and a rubber 
cup combined with irrigation with chlorhexidine and systemic antibiotics  
results in the reduction of anaerobic bacteria and bleeding scores in patients with  
peri-implantitis [80].
9.6 Laser therapy
Laser treatment using CO2, diode-, Er:YAG- (erbium-doped: yttrium-aluminum-
garnet), and Er, Cr: YSGG- (erbium, chromium-doped: yttrium-scandium-gallium-
garnet) lasers are used in the treatment of peri-implant diseases [81, 82]. The use 
of Er:YAG lasers showed significantly better results than mechanical methods in 
terms of bleeding at peri-implantitis [83]. Er:YAG and Er, Cr: YAG with a wavelength 
of 3 microns can reduce biofilms up to 90%, but in contrast to most mechanical 
therapies, any biological compatibilities and cell stimulatory properties cannot 
be re-induced [84]. The CO2 excimer laser was effective in reducing the anaerobic 
bacteria [85].
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9.7 Photodynamic therapy
Photodynamic therapy has to be considered as an additional treatment option 
in peri-implantitis. Photodynamic therapy generates reactive oxygen species 
by multiplicity with help of a high-energy single-frequency light in combina-
tion with photosensitizers. In a wavelength range of 580–1400 nm and toluidine 
blue-concentrations between 10 and 50 μg/mL, photodynamic therapy generates 
bactericide effects against aerobic and anaerobic bacteria such as Aggregatibacter 
actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Streptococcus 
mutans, Enterococcus faecalis [86, 87]. An improvement in both clinical attachment 
and the bleeding index was observed on a moderate and severe peri-implantitis 
with phototherapy [88]. Photodynamic therapy has been tried as an adjunctive to 
manual debridement and local chemotherapeutic agents [89].
9.8 Surgical therapy
Surgical techniques may include open flap debridement with removal of the 
inflammatory tissue as well as mechanical and chemical decontamination of the 
exposed implant surface. Recontouring of the bony architecture and smoothing 
of the implant surface may improve infection control [90]. The surgical flap helps 
in comprehensive debridement and decontamination of the affected implant. The 
surgical resection is generally confined to implants placed in non-esthetic sites [91].
9.9 Regenerative approaches
Regenerative procedures using a membrane and bone graft substitutes attempt-
ing to partially fill the bony defects caused by peri-implantitis can be successful 
[92]. Therapy of peri-implantitis followed by regular supportive care resulted in 
favorable clinical improvements and stable peri-implant bone levels in the majority 
of patients according to a systematic review (Figure 5) [93].
9.10 Resective therapy
Resective surgery has been shown to be effective in the reduction of BOP, 
probing depths and clinical signs of inflammation. The basic principles include the 
elimination of the peri-implant osseous defect using ostectomy and osteoplasty as 
well as bacterial decontamination. Additionally, smoothening and polishing of the 
Figure 5. 
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supracrestal implant surface may be done. Surgical pocket elimination and bone 
recontouring in combination with plaque control before and after surgery showed 
effective in treating peri-implantitis [94].
10. Prevention and maintenance
Besides, a maintenance program with regular evaluation of the peri-implant 
probing depths, supportive professional implant cleaning, and oral hygiene training 
should be an integral part of every post-operative care after implant insertion [95]. 
The establishment of an adequate oral hygiene should, therefore, be considered as 
the key issue of the prevention of peri-implantitis infections.
11. Conclusion
Peri-implantitis is an inflammatory disease of microbial origin causing bone 
loss around the implant, which could lead to the loss of the implant. The etiology 
of peri-implantitis is associated with a complex microbial biofilm and risk fac-
tors such as smoking and diabetes. Occlusal overloading, osteoporosis, and other 
factors compromising the surgical site might adversely affect the severity of the 
destruction of the peri-implant tissue. Several surgical and non-surgical therapeutic 
approaches have been proposed to manage this complex-multifactorial condition. 
Anti-infective and regenerative therapeutic strategies were used to restore the peri-
implant health as well as to achieve new bone-to-implant contact.
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